Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that injecting dutasteride into the skin (mesotherapy) can effectively treat common hair loss in both men and women.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Afatinib often causes skin problems that need proactive management.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Upadacitinib effectively treats severe alopecia areata and is safe.

Testosterone undecanoate caused hair loss; finasteride improved it but caused stomach issues for one patient.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

The treatment improved hair growth and was well-received without side effects.

Both LNG-IUD and systemic progestins are effective for fertility-sparing treatment, but close monitoring is needed due to recurrence risk.

Oral 5-alpha reductase inhibitors do not increase breast cancer or benign breast disorder risk in women.

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

Goserelin injections can effectively manage hyperandrogenism symptoms in postmenopausal women who can't have surgery.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

Hormone Replacement Therapy improves skin health in postmenopausal women by boosting collagen and hydration.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Presurgical models can effectively and affordably screen cancer prevention agents.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

The consensus provides guidelines for safely stopping danazol in hereditary angioedema treatment.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.